Louis Moore Bacon's BSX Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 189,256 shares of Boston Scientific Corporation (BSX) worth $8.08 M, representing 0.12% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 479,888 shares. Largest reduction occurred in Q2 2021, reducing 556,409 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +189,256 | New Buy | 189,256 | $42.68 |
| Q2 2023 | -100,000 | Sold Out | 0 | $0.00 |
| Q1 2023 | +100,000 | New Buy | 100,000 | $50.03 |
| Q4 2022 | -479,888 | Sold Out | 0 | $0.00 |
| Q3 2022 | +479,888 | New Buy | 479,888 | $38.73 |
| Q2 2022 | -358,472 | Sold Out | 0 | $0.00 |
| Q1 2022 | +14,330 | Add 4.16% | 358,472 | $44.29 |
| Q4 2021 | +344,142 | New Buy | 344,142 | $42.48 |
| Q2 2021 | -556,409 | Sold Out | 0 | $0.00 |
| Q1 2021 | +47,775 | Add 9.39% | 556,409 | $38.65 |
| Q4 2020 | +179,632 | Add 54.60% | 508,634 | $35.95 |
| Q3 2020 | +179,002 | Add 119.33% | 329,002 | $38.21 |
| Q2 2020 | +150,000 | New Buy | 150,000 | $35.11 |
Louis Moore Bacon's Boston Scientific Corporation Investment FAQs
Louis Moore Bacon first purchased Boston Scientific Corporation (BSX) in Q2 2020, acquiring 150,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Boston Scientific Corporation (BSX) for 13 quarters since Q2 2020.
Louis Moore Bacon's largest addition to Boston Scientific Corporation (BSX) was in Q3 2022, adding 479,888 shares worth $18.59 M.
According to the latest 13F filing for Q2 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 189,256 shares of Boston Scientific Corporation (BSX), valued at approximately $8.08 M.
As of the Q2 2026 filing, Boston Scientific Corporation (BSX) represents approximately 0.12% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Boston Scientific Corporation (BSX) was 556,409 shares, as reported at the end of Q1 2021.